| scholarly article | Q13442814 |
| P50 | author | Andrew P Scheibe | Q88140320 |
| P2093 | author name string | Adrian Puren | |
| Katherine Young | |||
| Mark W Sonderup | |||
| Nishi Prabdial-Sing | |||
| Harry Hausler | |||
| C Wendy Spearman | |||
| Anna Versfeld | |||
| P2860 | cites work | Hepatitis C in sub-Saharan Africa: the current status and recommendations for achieving elimination by 2030. | Q43923983 |
| Hepatitis B in sub-Saharan Africa: strategies to achieve the 2030 elimination targets. | Q43923988 | ||
| Hepatitis C virus infection rate in volunteer blood donors from the Western Cape--comparison of screening tests and PCR. | Q44789228 | ||
| Hepatitis C: A South African literature review and results from a burden of disease study among a cohort of drug-using men who have sex with men in Cape Town, South Africa | Q47274138 | ||
| Progress towards the 2020 targets for HIV diagnosis and antiretroviral treatment in South Africa. | Q54974619 | ||
| Intimate relationships and patterns of drug and sexual risk behaviors among people who inject drugs in Kazakhstan: A latent class analysis | Q57298094 | ||
| Predictors of male condom use among sexually active heterosexual young women in South Africa, 2012 | Q58700930 | ||
| Hepatitis C prevalence in HIV-infected heterosexual men and men who have sex with men | Q59357019 | ||
| The hepatitis C cascade of care in people who inject drugs in Dar es Salaam, Tanzania | Q59357604 | ||
| Understanding hepatitis B, hepatitis C and HIV among people who inject drugs in South Africa: findings from a three-city cross-sectional survey | Q64055184 | ||
| HIV infection among MSM who inject methamphetamine in 8 US cities | Q64136858 | ||
| Seroprevalence of hepatitis B virus: Findings from a population-based household survey in KwaZulu-Natal, South Africa | Q92771949 | ||
| Developing an advocacy agenda for increasing access to opioid substitution therapy as part of comprehensive services for people who use drugs in South Africa | Q93026052 | ||
| Status of HIV and hepatitis C virus infections among prisoners in the Middle East and North Africa: review and synthesis | Q26745482 | ||
| Sexually acquired hepatitis C virus infection: a review | Q26748542 | ||
| Hepatitis C treatment access and uptake for people who inject drugs: a review mapping the role of social factors | Q26853671 | ||
| Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention | Q27014761 | ||
| Prevalence and burden of HCV co-infection in people living with HIV: a global systematic review and meta-analysis | Q30251862 | ||
| Epidemiology and impact of HIV coinfection with hepatitis B and hepatitis C viruses in Sub-Saharan Africa. | Q30364080 | ||
| Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. | Q30984322 | ||
| Using a programmatic mapping approach to plan for HIV prevention and harm reduction interventions for people who inject drugs in three South African cities | Q33776451 | ||
| Unsafe injections in the developing world and transmission of bloodborne pathogens: a review | Q33791766 | ||
| Non-communicable diseases in sub-Saharan Africa: what we know now. | Q34180953 | ||
| Modelling the UNAIDS 90-90-90 treatment cascade for gay, bisexual and other men who have sex with men in South Africa: using the findings of a data triangulation process to map a way forward | Q36356389 | ||
| Generating trust: Programmatic strategies to reach women who inject drugs with harm reduction services in Dar es Salaam, Tanzania | Q36792005 | ||
| Prevalence and associations with hepatitis B and hepatitis C infection among HIV-infected adults in South Africa. | Q37047724 | ||
| Availability of HIV prevention and treatment services for people who inject drugs: findings from 21 countries | Q37151801 | ||
| Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity | Q37978441 | ||
| Influence of different drugs on HIV risk in people who inject: systematic review and meta-analysis | Q38315761 | ||
| High HIV and hepatitis C prevalence amongst injecting drug users in Mauritius: findings from a population size estimation and respondent driven sampling survey | Q38489016 | ||
| Global genotype distribution of hepatitis C viral infection among people who inject drugs | Q38926642 | ||
| Epidemiology of hepatitis B virus infection in the Asia-Pacific region | Q39543484 | ||
| HIV prevalence and risk among people who inject drugs in five South African cities | Q40010582 | ||
| Stigma and HIV disclosure in the Cape Metropolitan area, South Africa. | Q40219000 | ||
| Hepatitis C genotype distribution in patient and blood donor samples in South Africa for the period 2008-2012. | Q40498701 | ||
| Hepatitis C in sub-saharan Africa: urgent need for attention | Q41453798 | ||
| Estimating the number of sex workers in South Africa: rapid population size estimation | Q41548064 | ||
| Prevention, treatment and care of hepatitis C virus infection among people who inject drugs | Q41729675 | ||
| Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: a multistage systematic review | Q42699381 | ||
| P433 | issue | 1 | |
| P921 | main subject | prevention of HIV/AIDS | Q7242372 |
| P304 | page(s) | 655 | |
| P577 | publication date | 2020-09-07 | |
| P1433 | published in | BMC Infectious Diseases | Q15759919 |
| P1476 | title | Hepatitis B, hepatitis C and HIV prevalence and related sexual and substance use risk practices among key populations who access HIV prevention, treatment and related services in South Africa: findings from a seven-city cross-sectional survey (2017) | |
| P478 | volume | 20 |
Search more.